Compare · CPUH vs MACA
CPUH vs MACA
Side-by-side comparison of Compute Health Acquisition Corp. (CPUH) and Moringa Acquisition Corp (MACA): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CPUH and MACA operate in Blank Checks (Finance), so they compete in similar markets.
- CPUH is the larger of the two at $1.05B, about 7.3x MACA ($143.8M).
Compute Health Acquisition Corp.
Compute Health Acquisition Corp. focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 2020 and is based in Wilmington, Delaware.
Moringa Acquisition Corp
Moringa Acquisition Corp does not have significant operations. The company intends to acquire assets and businesses through a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities. It focuses on pursuing opportunities in technology-based businesses or industries in Israel. The company was incorporated in 2020 and is based in New York, New York.
Latest CPUH
- SEC Form 15-12G filed by Compute Health Acquisition Corp.
- SEC Form 4: Compute Health Sponsor Llc was granted 2,088,327 shares and returned 2,088,327 shares to the company (Amendment)
- SEC Form 4: Harsh Michael was granted 21,120 shares and returned 31,120 shares to the company, closing all direct ownership in the company
- SEC Form 4: Watanabe Gwendolyn A was granted 21,120 shares and returned 21,120 shares to the company
- SEC Form 25-NSE filed by Compute Health Acquisition Corp.
- Allurion Debuts as a Publicly Traded Company on the NYSE
- SEC Form DEFA14A filed by Compute Health Acquisition Corp.
- Compute Health Acquisition Corp. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
- Compute Health Acquisition Corp. Stockholders Approve Business Combination with Allurion
- SEC Form 425 filed by Compute Health Acquisition Corp.
Latest MACA
- PESG Releases Report on Silexion Therapeutics: Pioneering RNAi Technology in the Fight Against KRAS-Driven Cancers
- Amendment: SEC Form SCHEDULE 13G/A filed by Moringa Acquisition Corp
- SEC Form 15-12G filed by Moringa Acquisition Corp
- Moringa Acquisition Corp filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Unregistered Sales of Equity Securities, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits
- SEC Form 25-NSE filed by Moringa Acquisition Corp
- Silexion Therapeutics Ltd. and Moringa Acquisition Corp Announce Closing of their Business Combination
- SEC Form 10-Q filed by Moringa Acquisition Corp
- Moringa Acquisition Corp filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- SEC Form DEFM14A filed by Moringa Acquisition Corp
- Moringa Acquisition Corp filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits